Financial Ratios

TORRENT PHARMACEUTICALS LTD.

NSE : TORNTPHARMBSE : 500420ISIN CODE : INE685A01028Industry : Pharmaceuticals & DrugsHouse : Torrent
BSE2561.2524.6 (+0.97 %)
PREV CLOSE ( ) 2536.65
OPEN PRICE ( ) 2547.60
BID PRICE (QTY) 2564.70 (8)
OFFER PRICE (QTY) 2568.30 (2)
VOLUME 1429
TODAY'S LOW / HIGH ( )2533.35 2579.30
52 WK LOW / HIGH ( )1564 2745.55
NSE2566.0028.4 (+1.12 %)
PREV CLOSE( ) 2537.60
OPEN PRICE ( ) 2555.00
BID PRICE (QTY) 2566.00 (8)
OFFER PRICE (QTY) 2567.40 (4)
VOLUME 142594
TODAY'S LOW / HIGH( ) 2532.00 2580.10
52 WK LOW / HIGH ( )1564.55 2744
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)31.0658.5867.2355.4544.05
   CEPS(Rs)50.9347.0951.6345.6539.13
   DPS(Rs)22.0048.0035.0032.0017.00
   Book NAV/Share(Rs)190.75374.94356.30302.59296.34
   Tax Rate(%)33.3332.3816.7115.9620.29
Margin Ratios
   Core EBITDA Margin(%)31.4230.6033.4530.6427.69
   EBIT Margin(%)23.9024.8025.9524.7324.31
   Pre Tax Margin(%)20.1021.3620.8517.8516.05
   PAT Margin (%)13.4014.4417.3715.0012.80
   Cash Profit Margin (%)21.9723.2226.6824.7022.73
Performance Ratios
   ROA(%)8.758.669.667.876.25
   ROE(%)16.4316.0220.4118.5215.58
   ROCE(%)18.1016.9416.3014.6813.46
   Asset Turnover(x)0.650.600.560.520.49
   Sales/Fixed Asset(x)0.700.690.660.650.63
   Working Capital/Sales(x)15.154.554.2114.498.81
Efficiency Ratios
   Fixed Capital/Sales(x)1.431.451.511.541.58
   Receivable days76.0982.0485.0583.5777.19
   Inventory Days79.0898.6195.2583.6083.26
   Payable days117.53136.79163.65158.89181.40
Valuation Parameters
   PER(x)49.4923.8718.9017.7822.16
   PCE(x)30.1929.6924.6121.5924.95
   Price/Book(x)8.067.467.136.526.59
   Yield(%)1.431.721.381.620.87
   EV/Net Sales(x)7.347.507.346.216.67
   EV/Core EBITDA(x)22.1621.9520.4917.7819.26
   EV/EBIT(x)30.1129.7227.8324.7527.13
   EV/CE(x)4.394.544.033.243.19
   M Cap / Sales6.767.026.675.415.73
Growth Ratio
   Net Sales Growth(%)14.134.524.577.0435.77
   Core EBITDA Growth(%)10.50-0.227.257.9760.93
   EBIT Growth(%)10.110.139.899.2665.47
   PAT Growth(%)6.05-12.8721.2425.9054.64
   EPS Growth(%)-46.97-12.8721.2425.9054.64
Financial Stability Ratios
   Total Debt/Equity(x)0.710.530.731.041.12
   Current Ratio(x)1.151.621.601.131.21
   Quick Ratio(x)0.690.900.880.690.78
   Interest Cover(x)6.307.215.093.592.94
   Total Debt/Mcap(x)0.090.070.100.160.17

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.